ArticleDrug design, development and therapy2017

Efficacy and safety of direct-acting antiviral therapy in previous hard-to-treat patients with recurrent hepatitis C virus infection after liver transplantation: a real-world cohort.

Sebastian Bernuth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.